tiprankstipranks
Advertisement
Advertisement

BYSI Stock Latest News

BeyondSpring Announces Major Leadership Transition and New CEO
Company AnnouncementsBeyondSpring Announces Major Leadership Transition and New CEO
17d ago
8K
BYSI
BeyondSpring appoints Min Qiu as CEO, Na Li as CFO
PremiumThe Fly
BeyondSpring appoints Min Qiu as CEO, Na Li as CFO
17d ago
BYSI
BeyondSpring announces updated data from 303 Study
PremiumThe Fly
BeyondSpring announces updated data from 303 Study
19d ago
BYSI
Beyondspring Delays Second Closings of Share Sale
PremiumCompany Announcements
Beyondspring Delays Second Closings of Share Sale
6M ago
8K
BYSI
BeyondSpring presents Phase 3 DUBLIN-3 data at ESMO Asia Congress
PremiumThe Fly
BeyondSpring presents Phase 3 DUBLIN-3 data at ESMO Asia Congress
6M ago
BYSI
BeyondSpring’s Plinabulin combination shows survival benefit in NSCLC
PremiumThe FlyBeyondSpring’s Plinabulin combination shows survival benefit in NSCLC
6M ago
BYSI
BeyondSpring Completes $2 Million Securities Agreement
Premium
Company Announcements
BeyondSpring Completes $2 Million Securities Agreement
7M ago
8K
BYSI
BeyondSpring Inc. Reports Q3 2025 Earnings and Strategic Shift
Premium
Company Announcements
BeyondSpring Inc. Reports Q3 2025 Earnings and Strategic Shift
7M ago
BYSI
BeyondSpring reports Q3 EPS (4c) vs (5c) last year
PremiumThe Fly
BeyondSpring reports Q3 EPS (4c) vs (5c) last year
7M ago
BYSI
SEED Therapeutics Secures $6M in Series A-3 Financing
PremiumCompany Announcements
SEED Therapeutics Secures $6M in Series A-3 Financing
9M ago
8K
BYSI
Beyondspring Shareholders Ratify Accounting Firm Appointment
PremiumCompany Announcements
Beyondspring Shareholders Ratify Accounting Firm Appointment
9M ago
8K
BYSI
BeyondSpring’s Q2 2025: Clinical Advances and Strategic Moves
PremiumCompany Announcements
BeyondSpring’s Q2 2025: Clinical Advances and Strategic Moves
10M ago
BYSI
BeyondSpring reports Q2 EPS (10c) vs (4c) last year
PremiumThe FlyBeyondSpring reports Q2 EPS (10c) vs (4c) last year
10M ago
BYSI
BeyondSpring announces publication of human clinical study on plinabulin
Premium
The Fly
BeyondSpring announces publication of human clinical study on plinabulin
12M ago
BYSI
BeyondSpring presents interim phase 2 data on 303 study
Premium
The Fly
BeyondSpring presents interim phase 2 data on 303 study
1y ago
BYSI
BeyondSpring Reports Q1 2025 Financials and Clinical Progress
PremiumCompany Announcements
BeyondSpring Reports Q1 2025 Financials and Clinical Progress
1y ago
BYSI
BeyondSpring’s 2024 Progress and Strategic Milestones
PremiumCompany Announcements
BeyondSpring’s 2024 Progress and Strategic Milestones
1y ago
BYSI
BeyondSpring reports FY24 EPS (21c) vs. (34c) last year
PremiumThe Fly
BeyondSpring reports FY24 EPS (21c) vs. (34c) last year
1y ago
BYSI
BeyondSpring announces expected 2025 milestones
PremiumThe Fly
BeyondSpring announces expected 2025 milestones
1y ago
BYSI
SEED receives FDA Rare Pediatric Disease, Orphan Drug designations for ST-01156
PremiumThe FlySEED receives FDA Rare Pediatric Disease, Orphan Drug designations for ST-01156
1y ago
BYSI
BeyondSpring to sell portion of equity interest in SEED for $35.4MEli Lilly
Premium
The Fly
BeyondSpring to sell portion of equity interest in SEED for $35.4MEli Lilly
1y ago
LLY
BYSI
BeyondSpring presents efficacy results from Phase 2 IIT study of plinabulin
Premium
The Fly
BeyondSpring presents efficacy results from Phase 2 IIT study of plinabulin
2y ago
BYSI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >